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Abstract
Background: The Researching Effective Approaches to Cleaning in Hospitals (REACH) study will generate evidence
about the effectiveness and cost-effectiveness of a novel cleaning initiative that aims to improve the environmental
cleanliness of hospitals. The initiative is an environmental cleaning bundle, with five interdependent, evidence-based
components (training, technique, product, audit and communication) implemented with environmental services staff
to enhance hospital cleaning practices.
Methods/design: The REACH study will use a stepped-wedge randomised controlled design to test the study
intervention, an environmental cleaning bundle, in 11 Australian hospitals. All trial hospitals will receive the intervention
and act as their own control, with analysis undertaken of the change within each hospital based on data collected in the
control and intervention periods. Each site will be randomised to one of the 11 intervention timings with staggered
commencement dates in 2016 and an intervention period between 20 and 50 weeks. All sites complete the trial at the
same time in 2017. The inclusion criteria allow for a purposive sample of both public and private hospitals that have
higher-risk patient populations for healthcare-associated infections (HAIs). The primary outcome (objective one) is
the monthly number of Staphylococcus aureus bacteraemias (SABs), Clostridium difficile infections (CDIs) and
vancomycin resistant enterococci (VRE) infections, per 10,000 bed days. Secondary outcomes for objective one
include the thoroughness of hospital cleaning assessed using fluorescent marker technology, the bio-burden of
frequent touch surfaces post cleaning and changes in staff knowledge and attitudes about environmental
cleaning. A cost-effectiveness analysis will determine the second key outcome (objective two): the incremental
cost-effectiveness ratio from implementation of the cleaning bundle.
The study uses the integrated Promoting Action on Research Implementation in Health Services (iPARIHS)
framework to support the tailored implementation of the environmental cleaning bundle in each hospital.
Discussion: Evidence from the REACH trial will contribute to future policy and practice guidelines about
hospital environmental cleaning. It will be used by healthcare leaders and clinicians to inform decision-making
and implementation of best-practice infection prevention strategies to reduce HAIs in hospitals.
Trial registration: Australia New Zealand Clinical Trial Registry ACTRN12615000325505
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Background
Healthcare-associated infections (HAIs) are a major
cause of avoidable costs, morbidity and deaths among
hospital patients [1]. In Australia, 200,000 cases of HAI
arise each year and 1.9 million hospital bed days are
diverted to treat them [1]. Reducing HAIs requires
successful implementation of multiple evidence-based
approaches [2].
While reasonable knowledge exists on many aspects
of HAI prevention and control, good quality data on
the effectiveness of hospital environmental cleaning
programmes are limited. The healthcare environment
plays a key role in the transmission of HAIs [3–5].
Environmental cleaning and evaluating cleanliness is
therefore a critical component of HAI prevention. Most
research examining the association between cleaning
and reduction of infections has been based on a single
ward or hospital using quasi-experimental designs [6].
There is little published evidence on cleaning relating
to intervention cost, cost-effectiveness, feasibility and
acceptability. Decision makers need more rigorous evi-
dence from randomised controlled trials in real-world
settings [7].
Environmental cleaning in hospitals is a complex
process, and implementing and sustaining effective
cleaning programmes is challenging [4, 8]. A review
of hospital cleaning in Australian hospitals found
great heterogeneity in cleaning practices between
hospitals even though there are detailed cleaning
guidelines [9, 10].
Using bundles to improve implementation of complex
interventions
A bundle is a set of evidence-based practices that when
performed collectively and reliably have a proven ability
to improve patient outcomes [11]. Using a bundle is a
structured way to introduce a number of interventions
concurrently, improving implementation and impact on
processes of care.
An environmental cleaning initiative that combines
multiple evidence-based interventions within a ‘clean-
ing bundle’ has the potential to improve the effective-
ness of hospital cleaning by including strategies to
educate, provide feedback and empower healthcare
workers. A multi-site trial of an environmental clean-
ing bundle will allow a change in cleaning policy and
practice to be evaluated in real-world settings to de-
termine efficacy and cost-effectiveness. This trial will
provide evidence that can be used by clinicians and
decision makers to inform future environmental
cleaning and infection prevention in hospitals. This
trial is called Researching Effective Approaches to
Cleaning in Hospitals (REACH).
Trial objectives
Objective 1
The first objective is to evaluate the effectiveness of
an environmental cleaning bundle to reduce HAIs in
Australian hospitals.
Objective 2
The second objective is to estimate the cost-
effectiveness of a decision to adopt the environmen-
tal cleaning bundle for Australian hospitals.
Methods/design
Study design
Stepped-wedge design
This is a randomised controlled trial using a cross-
sectional stepped-wedge random allocation [12]. There
will be sequential roll-out of an environmental cleaning
bundle intervention to 11 Australian public and private
hospitals over 62 weeks. Example trial timings are shown
in Fig. 1.
All hospitals will receive the intervention and act as
their own control, with analysis undertaken of the
change within each hospital based on data collected in
the control and intervention phases. The stepped-wedge
design, with staggered commencement timings and
intervention length (20–50 weeks), supports feasibility
while maintaining the rigour of the study. This design
will allow research staff to work with individual hospitals
as they change-over, maximising consistency of imple-
mentation of the cleaning bundle and avoiding managing
change at 11 sites across Australia simultaneously. This
design also avoids having control hospitals that get no
intervention, which could make it difficult to recruit
hospitals, and ensures equity. Each hospital acting as
their own control avoids inconsistencies in comparing
infection control programmes across hospitals and
jurisdictions.
Implementation framework
The project will use the integrated Promoting Action on
Research Implementation in Health Services (iPARIHS)
[13] framework to promote the successful implementa-
tion of the evidence-based intervention at trial sites [14].
This framework has key constructs of innovation (e.g.
the cleaning bundle), recipients (e.g. the environmental
services staff ) and context (e.g. hospital characteristics)
that are underpinned by a fourth construct of facilitation
(e.g. engagement strategies) [13].
Study population
Eleven large acute public and private Australian hospi-
tals that fulfil the inclusion criteria and agree to partici-
pate will be enrolled in the study. These criteria are that
each hospital:
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1. Has an intensive care unit (ICU) accredited for
advanced clinician training by the College of
Intensive Care Medicine of Australia & New
Zealand [15]
2. Is classified by the National Health Performance
Authority (NHPA) as a major hospital (public
hospital) or has over 200 in-patient beds (private
hospital) [16]
3. Has an established HAI surveillance programme that
collects data on Staphylococcus aureus bacteraemia
(SAB) infections, Clostridium difficile infections
(CDIs) and vancomycin resistant enterococci (VRE)
infections
Recruitment
The study team will list all eligible sites then order the list
to ensure (i) a representation of both private and public
hospitals and (ii) representation from at least four
Australian states and territories. The recruitment
process will purposively select and approach eligible
hospitals to optimise the feasibility and practicality of
completing the trial.
The intervention
Developing and piloting
In 2014, Allen and colleagues, from the National Health
and Medical Research Council (NHMRC) Centre of
Research Excellence in Reducing Healthcare Associated
Infections (CRE-RHAI), conducted a single-site pilot of
an environmental cleaning behavioural change bundle.
The bundle components were agreed, following a re-
view of the evidence and feasibility, by an expert panel
and piloted successfully at a large acute hospital in
Queensland in 2014 [17]. The pilot study demonstrated
that the intervention is acceptable to hospital staff, that
the outcomes can be reliably measured and that the
cleaning bundle is feasible [17].
Bundle components
The multimodal intervention has five interdependent
components, shown in Table 1, and will be delivered as
a hospital-wide intervention. For practical reasons the
cleaning audits will sample a percentage of wards only.
The other bundle components (training, technique,
product and communication) will be implemented
across the whole hospital to allow for staff relocation to
and from sample wards.
The bundle components reflect the current evidence
concerning hospital cleaning and HAIs about the posi-
tive impact of audit activities [18, 19], educational inter-
ventions [20, 21], clearly defined cleaning roles and
responsibilities [22] and correct product use along with
daily cleaning of the frequent touch points. Product and
technique components align with current Australian
Guidelines [23]. Communication, particularly a positive
feedback loop in association with audit [20, 22], and cre-
ation of a ‘culture of hygiene’ [24], will be emphasised
throughout the intervention phase.
Implementation
The study team will use the iPARIHS framework to sup-
port effective implementation of the cleaning bundle
intervention at each site [13, 14]. A tailored intervention
should optimise bundle implementation and compliance.
The tailoring will not compromise the integrity of the
individual components and the ‘sum of the whole’ of the
bundle.
Fig. 1 Example stepped-wedge trial timings over 62 weeks in 11 Australian hospitals
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Initially, we will map the hospital characteristics and
context (e.g. staffing, size), infection prevention policies
and practices (e.g. antimicrobial stewardship, antibiotic
use, screening) and conduct surveys. This will provide
the information to develop a tailored implementation
strategy for each site, based on behavioural change and
adult learning principles, current environmental cleaning
practices and other contextual factors.
Throughout the trial, we will monitor these character-
istics and other relevant activities (e.g. cleaning staff
changes, policy changes) within the hospital. Ongoing
reviews of contextual information throughout the inter-
vention at each site will assist with trial site comp-
arisons, replication and scalability and knowledge
translation.
Randomisation
Hospitals will be randomly allocated to intervention
timing once 11 sites have been enrolled. One of the chief
investigators (AGB, statistician) will be responsible for
computer generation of the allocation times and the
allocation of hospital identifiers. Hospitals will be in-
formed of their intervention start date 12 weeks before
the intervention commences. This 12-week period will
include 4 weeks of establishment/engagement activities
(‘establishment phase’) and 8 weeks of baseline data col-
lection (‘control phase’). Hospitals and research sites will
not be blinded because it is not possible to blind the
cleaning staff to the intervention.
Outcomes and data collection: objective 1: effectiveness
of the environmental cleaning bundle
Objective 1 outcomes and measures are shown in
Table 2.
Primary outcome—HAI rates
Whole hospital infection rates will be used as the pri-
mary outcome. This reflects the frequent movement of
staff, patients and cleaners across hospitals wards and
locations.
Hospitals will collect monthly data and then submit
it at least bi-monthly to the project team. The num-
bers of SABs, CDIs and clinical isolates of VRE will
be monitored, and rates calculated using algorithms
based on nationally agreed definitions, as published
by the Australian Commission on Safety and Quality
in Health Care (ACSQHC) [25].
Secondary outcome—thoroughness of routine hospital
cleaning
Thoroughness of hospital cleaning will be measured
using the DAZO® Fluorescent marking gel and ultravio-
let (UV) light system that dries on surfaces following ap-
plication and resists dry abrasion but is removed with
standard cleaning. A trial site staff member trained by
the study team will apply the gel dots on frequently
touched points in the patient cubicles as per the Centers
for Disease Prevention and Control Environmental
Cleaning Checklist [26]. On each audit occasion, dots
will be placed in two different beds and bathroom areas
in the ICU and in at least 50 % of the hospital trial site
wards. Wards will be prioritised according to NHPA risk
factors for patient vulnerability [16]. Cleaning staff will
be aware of the frequently touched points but will not
be aware of where the dots are actually applied or the
timing of audits.
After cleaning, the dot locations will be checked using
the UV light pen, which will show the extent of removal
of the dot by cleaning. All results will be entered directly
into a web-based application on a mobile device at the
time of data collection. Cleaning audits will take place in
the control and intervention periods. Feedback mecha-
nisms for staff will be implemented as part of the bundle
during the intervention period.
Table 1 Environmental cleaning bundle
Bundle component Key activities
Training - Tailored training activities with environmental
services staff at the commencement of the
intervention phase, as part of induction for
new cleaning staff, and as required throughout
the intervention phase
- Content to reflect the trial site context and
cleaning roles and responsibilities
Technique Attention to cleaning technique, including:
- A defined and consistent cleaning sequence
- A focus on cleaning high risk frequent touch
points
- The use of sufficient pressure and movement
- Adherence to manufacturers’ instructions for
product use
Product - Disinfectant minimally used for all discharge
cleans and for daily cleans of high
risk/precautions rooms
- Point of care wipes used for medical
equipment
Audit
- Audit activities across the trial site using
ultraviolet (UV) marker technology
(all trial sites) and adenosine tri-phosphate
(ATP) luminosity (3 trial sites)
- Regular audit feedback to cleaning staff
- Summarised audit results provided to clinical
governance committees
Communication - Promotion of a team approach
- Daily contact between cleaners and ward
leaders or managers
- Cleaners represented on relevant clinical
governance committees
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Other outcomes
Bio-burden of frequent touch surfaces We will rou-
tinely assess bio-burden on a selection of high touch
surfaces using adenosine tri-phosphate (ATP) luminosity
following cleaning in three of the 11 hospitals, using a
validated sampling process [27].
Knowledge and attitudes of environmental cleaning
staff The knowledge and attitudes of environmental
cleaning staff will be surveyed pre- and post-intervention
and will serve two purposes. First, it will provide an un-
derstanding of baseline hospital context, including know-
ledge, attitudes and practices of environmental services
staff, which will be used to tailor the educational compo-
nent of the cleaning bundle. Second, it will allow a com-
parison of knowledge and attitudes about environmental
cleaning between the pre- and post-intervention phases.
This is particularly important to gauge whether the bundle
has impacted not only upon behaviour but also on atti-
tudes and knowledge, which are the longer-term drivers of
behavioural outcomes.
Other surveillance data In areas of the hospital
where patient screening for multi-resistant organisms
is a standard practice (such as in ICU) and consist-
ently undertaken during the study period, data on
screening isolates, via nasal swabs for Methicillin-
resistant Staphylococcus aureus (MRSA) and stool or
peri-rectal swabs for VRE per 1000 patient days, will
also be collated.
Patient satisfaction surveys These will only be used if
an existing survey tool and process is used by the
hospital and if patient survey collation/report periods
align with the control and intervention timings at
that trial site.
Power calculation
Eleven hospitals with a pre-intervention infection rate (a
combination of SAB, CDI and VRE infections) of 5 per
10,000 patient days will give us 86 % power to detect a
20 % post-intervention reduction in infection risk. This
is based on a two-sided 5 % significance level, a within-
hospital correlation in infection rates of 0.3 and the
intervention timings shown in Fig. 1. The pre-
intervention infection rate and within-hospital correl-
ation were estimated using a dataset of over two million
hospital admissions and infection data from nine
Queensland hospitals [28]. The stepped-wedge sample
size formula is from Hussey and Hughes [29]. We as-
sumed no delay in the treatment effect for the sample
size calculation, that is, rates decline as soon as the
intervention begins.
Table 2 Objective 1 outcomes and measures
Outcome Measure Method
Primary outcome
Healthcare-associated infection
(HAI) rates in each trial site
Numbers of Staphylococcus aureus bacteraemia (SAB),
Clostridium difficile infection (CDI) and clinical isolates of
vancomycin resistant enterococci (VRE) and monthly
rates per 10,000 occupied bed days
Datasets include all patients across the hospital with
a HAI, and data on occupied bed daysCollated from:-
Hospital infection data and reports for ongoing
surveillance- Hospital occupied bed days reports
Secondary outcome
Hospital cleaning
performance—thoroughness
of hospital cleaning in each
trial site
Number and percentage of ultraviolet (UV) gel dots
removed completely following cleaning
DAZO® Fluorescent Marking Gel dots applied to
frequent touch sites around two patient cubicle and
bathroom areas in the intensive care unit (ICU) and
the highest risk wards
Other outcomes—study specific data set
Bio-burden of frequent touch
surfaces post cleaning
Levels of organic matter in relative light units
(RLUs) post cleaning in three hospitals
Adenosine tri-phosphate (ATP) bioluminescence
measurements
Other outcomes—study specific data set
Changes in staff knowledge
and attitudes around
environmental cleaning
Pre-intervention educational needs. Pre- and
post-intervention knowledge and attitudes about
environmental cleaning and job roles
Environmental services staff questionnaires and
discussion groups
Other outcomes—existing data set
Changes in rates of screening
and clinical isolates
Numbers of positive clinical isolates of other
multi-resistant organisms per 1000 patient days at risk
Collated from hospital infection data and reports,
where available for ongoing surveillance and supplied
to project team by trial site team
Other outcomes—existing data set
Changes in patients’
perception of hospital cleanliness
Patients’ perceptions of cleanliness Collated from existing hospital-based survey data,
where available and supplied to project team by trial
site team
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To detect an increase in the secondary outcome (thor-
oughness of cleaning) from 82 to 87 % due to the inter-
vention with a 92 % power requires only five hospitals
with 40 observations per hospital per 4 weeks. This is
based on the pilot data and recent studies [17, 22, 30, 31].
This secondary hypothesis requires far fewer hospitals
because the outcome of cleaning failure is likely to be
more common than HAIs (primary outcome), which are
relatively rare.
Analysis
Infection rates Infection rates will be analysed using
Poisson regression with the infection counts as the
dependent variable and the weekly number of patient
days as the denominator. The key independent variable
will be the intervention (yes/no). The intervention vari-
able will switch from “no” to “yes” after the first full
month of the intervention. The model will include a lin-
ear term for calendar time to control for any long-term
pattern in infection rates. It will be a generalised linear
mixed model (GLMM) with a random intercept for each
hospital [29].
The characteristics of the hospital (e.g. size) will not
be independent variables as these should remain roughly
constant throughout the study. We will test the residuals
of the model to look for autocorrelation over time and
will check for influential observations. In a sensitivity
analysis we will consider the possibility of a delayed
intervention effect of up to one month. This is plausible
because it may take time for the intervention to break
the cycle of infection transmission.
The primary outcome will be a fixed effect meta-
analysis of the estimated change in infection rates across
the three infection types. We will use a forest plot to
visually examine the variation in the change in infection
rates. The combined mean will be considered statistically
significant if the 95 % confidence limit does not include
zero. The meta-analytic approach avoids using a com-
bined infection rate, as this is questionable given the
different drivers of infection. However, it will still give an
overall estimate of the interventions impact on HAIs.
Thoroughness of cleaning Success or failure of envir-
onmental cleaning as measured by the removal of invis-
ible gel dots will be examined using a GLMM with a
binomial response (clean/not clean). This will model the
probability of success as the number of successfully
clean sites divided by the total number of sites marked.
The independent variables will be the intervention
(yes/no) and the dot location (e.g., ICU, toilet). The
model will include a random intercept for each hospital,
which focuses the analysis on within-ward change by
removing each wards underlying success rate. We will
test two models with independent variables of:
1. A simple binary intervention (yes/no)
2. A linear intervention using the time since
intervention (0, 1, 2, etc.)
The linear model allows for a gradual improvement in
success rates. We will compare the fit of the two models
using the Akaike Information Criterion [32].
Bio-burden of high touch surfaces The total amount
of ATP, both microbial and non-microbial, will be quan-
tified and expressed as relative light units. This will be
correlated with the secondary outcome data (thorough-
ness of cleaning).
Changes in staff knowledge and attitudes Several pre-
existing scales from the literature will be used to assess
both the attitudes and knowledge of environmental
cleaning staff [33–36]. Paired t tests (or Wilcoxon
signed-rank tests) will be used to analyse the changes in
attitudes between the pre- and post-intervention phases.
Change in knowledge will be assessed as the difference
in the proportion of correct responses at time 1 versus
time 2, tested using McNemar’s test. General perceived
organisational support will also be assessed in a short
eight-item measure [37].
Other surveillance data The changes in rates of posi-
tive screening and clinical isolates will be examined as
per the primary outcome.
Changes in patient perceptions of hospital cleanliness
As there are likely to be differences in the questions
used between hospitals, we will estimate the change
within each hospital and then combine these using a
meta-analysis. To provide estimates on a common scale,
we will look at the percentage change from baseline.
Outcomes and data collection: objective 2: cost-effectiveness
of the environmental cleaning bundle
Objective 2 outcomes and data measures and processes
are shown in Table 3.
The perspective used to evaluate the cost-effectiveness
of the environmental cleaning bundle will be that of the
health system. The timeframe will be the duration of the
trial (62 weeks). All costs will be presented in Australian
dollars for the current cost year 2016. Changes to health
benefits will be estimated in quality-adjusted life years
(QALYs). All costs and health benefits arising in future
periods will be appropriately discounted [38].
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Cost of implementing the bundle
Standard procedures for costing the intervention will be
followed and all resources used to implement the inter-
vention will be identified, measured and valued at local
market prices [38]. The main resources used in imple-
menting the bundle include staff time, costs of cleaning
products, invisible gels, ultraviolet lamps and pathology
costs. Resource use will be collected from each hospital
by a monthly survey. Using a standardised tool across all
hospitals and applying common cost vectors will ensure
consistency in collection of costs across all sites and
reduce uncertainty in estimates that often results from
using retrospective administrative data. Staff time will be
valued using full employment costs incurred at partici-
pating sites. Consumables will be valued at local market
prices based on purchase contracts for each hospital.
Potential cost savings from implementing the bundle
If the bundle reduces infection rates, it should also pro-
duce cost savings. A reduced rate of infection should
result in a lower average length of stay for patients and
lower costs associated with diagnosis and treatment of
infections [39]. Estimates of the number of antibiotics,
screening and diagnostic tests and medical and surgical
procedures avoided per infection will be based on stand-
ard treatment regimens for infection in participating
hospitals and valued using hospital supplied unit costs.
Estimates of the extra length of stay per infection
avoided and the value of these bed days will be based on
published estimates from recent high quality Australian
studies [40, 41].
Change in health benefits from implementing the bundle
Changes to health benefits will be informed by estimat-
ing the deaths prevented, life years gained and QALYs
gained as a result of fewer infections. The number of
deaths averted will be estimated using Australian data
on the attributable mortality associated with infection
[42, 43]. We will also estimate years of life gained (ac-
counting for observed age and comorbidities in the pa-
tient population), and finally, preference-based utility
scores from the published literature [44] will be used to
weight life expectancy, allowing the QALYs gained to be
calculated.
Cost-effectiveness analysis
The incremental cost-effectiveness ratio (ICER) will be
estimated by dividing the incremental change in total
costs incurred and benefits gained due to implementing
the bundle to give the incremental cost per QALY. Re-
sults will also be presented as the cost per infection pre-
vented to allow comparison with other infection control
interventions. The cleaning bundle will be considered
cost-effective if the cost per QALY is less than $64,000,
which is the willingness to pay for Australian QALYs and
cost-saving if there is a net reduction in costs [45].
Probabilistic sensitivity analyses will be used to esti-
mate the probability a decision to adopt the intervention
is cost effective, given the current uncertainties in the
observed parameters [46]. Sub-analyses will look at the
efficiency of the cleaning bundle at individual hospitals
to identify any systematic differences in the ICER that
may be related to hospital characteristics.
Ethics approval
This project has received ethics approval from the Uniting
Care Health Human Research Ethics Committee (approval
number 1413) and the Queensland University of Technol-
ogy Human Research Ethics Committee (approval number
1400000828). Local ethics approvals are being completed
for all participating hospital sites.
Trial status
At the time of manuscript submission, the REACH study
is beginning year 2. The study team is completing the
Table 3 Objective 2 outcomes and data sources
Outcomes Measures Methods
Primary outcome:
Incremental cost-effectiveness ratio from adoption of the cleaning bundle presented as cost per quality-adjusted life year (QALY) gained (calculated from
secondary outcomes)
Secondary outcomes:
1. Changes in costs associated
with implementing the bundle
Frequency and value of resources used in
implementing the bundle (costs incurred)
Hospital specific items collated from existing hospital-based
data sets and supplied to project team by trial site team for
analysis. Centralised resources recorded by project team.
Valued in 2016 Australian dollars (AUD)
Cost of infection in terms of treatment costs,
diagnosis costs and bed days saved (potential cost
savings)
Calculated using estimates from the literature about the
attributable cost of infection. Valued in 2016 AUD
2. Changes in QALYs
associated with
implementing the bundle
Opportunity cost of infection in terms of:
1. Deaths
2. QALYs
Calculated using estimates from the published literature on
attributable mortality and morbidity for infection
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recruitment of trial sites, multi-site ethical applications
and agreements prior to randomisation and allocation.
Discussion
Limitations
This trial requires 11 participating hospitals. It could be
difficult to recruit that number as it is very likely that
some hospitals will decline or be unable to participate.
This could be due to a number of reasons, e.g. disinter-
est in research, a lack of resources, a concern about
negative impact on hospital budgets due to the need to
implement change and increased product use associated
with participation. This will be addressed by following
an established recruitment process that provides clear
information about what is required and a focus on fos-
tering engagement and relationships with key decision
makers at each site.
Once enrolled, willingness to participate may waiver
for sites that are randomised to later trial commence-
ment times. This will be addressed by maintaining
communication with all sites and through ongoing mon-
itoring of site context and engagement. The potential for
fatigue related to participation, especially for the longer
intervention phase sites, will be managed through
frequent monitoring and engagement activities at the
trial site.
We recognise some possible limitations in relation to
the ‘opt-in’ nature of the recruitment process (i.e. that
participating hospitals may be those most receptive to
change and quality improvement). To mitigate this, we
will as much as possible approach a range of eligible
hospitals and will ensure we complete comprehensive
context mapping at each site to fully understand the
barriers and enablers that may have influenced the site’s
decision to participate.
Other limitations could occur due to adverse events
occurring at the staff, patient or hospital level during the
trial. This could include outbreaks of HAIs, seasonal
factors, organisational or policy changes. This will be
mitigated by frequent monitoring of each site. Participat-
ing sites will agree to not implement changes that could
impact the trial, e.g. cleaning policies or product use,
without prior agreement from the study team. If there is
a serious national epidemic during the trial the study
will continue to collect data, but any planned change-
overs to the intervention will be delayed until the
epidemic has passed.
Significance
Previous cleaning research has often focused on single
interventions, such as a new cleaning product or audit-
ing strategy. However, implementing cleaning in a hos-
pital setting is a multifaceted and complex process,
where contextual factors influence the success of a new
approach. This study, with its implementation science
approach and emphasis on facilitation and local hospital
context, will enable us to develop new insights into the
processes and impacts of hospital cleaning. These will be
used to assist with the translation of new knowledge
from each of the trial sites to other hospitals in Australia
and internationally.
The effectiveness and cost-effectiveness of a cleaning
bundle intervention will be evaluated to support
evidence-based decision-making in public and private
healthcare sectors about the impact of investment in an
environmental cleaning programme in acute hospitals,
particularly on the risks of HAIs. It will further show
whether this policy is cost-effective in a real world
setting, addressing an identified research gap [7].
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